ASBP
Aspire Biopharma Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.01
−2.59%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+77.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 10, 2025 | Fell Donald G. · director | Purchase | 10,500 | $0.39 |
| Jun 10, 2025 | Fell Donald G. · director | Purchase | 9,500 | $0.39 |
| Jun 6, 2025 | Fell Donald G. · director | Purchase | 10,500 | $0.39 |
| Jun 6, 2025 | Fell Donald G. · director | Purchase | 9,500 | $0.39 |
| Aug 22, 2023 | PowerUp Sponsor LLC · 10 percent owner | Sale | 4,317,500 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 0Increased 0Reduced 1Sold out 2
| Filer | Action | Shares | Filed |
|---|---|---|---|
| CROSSINGBRIDGE ADVISORS, LLC | Unchanged | 24,348 | May 14, 2026 |
| HALLMARK CAPITAL MANAGEMENT INC | Reduced | 1,000 | May 6, 2026 |
| Crossingbridge Advisors, LLC | Sold Out | 0 | May 14, 2026 |
| VALLEY WEALTH MANAGERS, INC. | Sold Out | 0 | May 6, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 10, 2025